Pricing Log in Create free account

Avenue Therapeutics, Inc. (ATXI) vs CDT Equity Inc. (CDT)

Avenue Therapeutics, Inc. and CDT Equity Inc. are both Biotechnology companies. Avenue Therapeutics, Inc. is the larger, with a market value of $680.0K against $390.0K — 1.7× the size. Across the 9 metrics below, CDT Equity Inc. leads on 5 and Avenue Therapeutics, Inc. on 4.

Valuation

Metric ATXI CDT Biotechnology median
P/E n/m n/m 10.60
P/S n/m n/m 9.40
P/B 2.49 0.00 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.05 n/m 0.66
EV/Sales n/m n/m 9.02
Earnings yield (197.67%) (10,527,125.00%) (32.88%)
Free cash flow yield (97.68%) (43,606.95%) (23.13%)

Profitability

Metric ATXI CDT Biotechnology median
Gross margin — — 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (163.30%) (69.68%) (51.96%)
Return on assets (90.50%) (55.16%) (46.06%)
Return on invested capital 0.00% (21.28%) 0.00%

Growth

Metric ATXI CDT Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 94.11% 98.09% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric ATXI CDT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.40 0.13 4.97
Net debt to EBITDA 0.93 0.05 1.01

Dividend

Metric ATXI CDT Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ATXI CDT Biotechnology median
Market cap 680.00k 390.00k 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack